2025 France Anti-Infective Vaccines Market Revenue Opportunities Report
Description
The 2025 France Anti-Infective Vaccines Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Anti-Infective Vaccines Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Anti-Infective Vaccines Market in France are GlaxoSmithKline (GSK), Sanofi, Merck & Co., and Pfizer Inc. GSK holds the largest market share (20-25%) with a comprehensive vaccine portfolio including vaccines for RSV and herpes zoster. Sanofi follows with a 15-20% share, focusing on various infectious disease vaccines, particularly meningococcal vaccines. Merck & Co. controls 12-15% of the market, notable for its pneumococcal vaccine Capvaxive which competes with Pfizer's Prevnar 20. Pfizer captures 10-12%, leading in pneumococcal vaccines with a strong global distribution network supporting its dominance.
Sanofi is a French multinational with strong commitments to R&D for unmet needs, including vaccines and rare disease treatments, supporting global health efforts like WHO’s vaccine initiatives. GSK and Pfizer, while global, also have significant vaccine operations affecting France's market. Merck & Co. similarly has a presence through approved vaccines competitive in the region. Other French-based biotech companies, such as OSE Immunotherapeutics, focus on next-generation immunotherapies but are smaller players relative to these pharmaceutical giants.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Anti-Infective Vaccines Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Anti-Infective Vaccines Market in France are GlaxoSmithKline (GSK), Sanofi, Merck & Co., and Pfizer Inc. GSK holds the largest market share (20-25%) with a comprehensive vaccine portfolio including vaccines for RSV and herpes zoster. Sanofi follows with a 15-20% share, focusing on various infectious disease vaccines, particularly meningococcal vaccines. Merck & Co. controls 12-15% of the market, notable for its pneumococcal vaccine Capvaxive which competes with Pfizer's Prevnar 20. Pfizer captures 10-12%, leading in pneumococcal vaccines with a strong global distribution network supporting its dominance.
Sanofi is a French multinational with strong commitments to R&D for unmet needs, including vaccines and rare disease treatments, supporting global health efforts like WHO’s vaccine initiatives. GSK and Pfizer, while global, also have significant vaccine operations affecting France's market. Merck & Co. similarly has a presence through approved vaccines competitive in the region. Other French-based biotech companies, such as OSE Immunotherapeutics, focus on next-generation immunotherapies but are smaller players relative to these pharmaceutical giants.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
